914910-55-7

Basic information

• Product Name: Benzonitrile, 4-fluoro-3-[hydroxy[3-[2-(1-piperidinyl)ethoxy]phenyl]methyl]-
• CAS NO: 914910-55-7
• Molecular Formula: C21H23FN2O2
• Molecular Weight: 354.424
• Mol File: 914910-55-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 4-fluoro-3-[hydroxy[3-[2-(1-piperidinyl)ethoxy]phenyl]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 4-fluoro-3-[hydroxy[3-[2-(1-piperidinyl)ethoxy]phenyl]methyl]-(914910-55-7)
• EPA Substance Registry System: Benzonitrile, 4-fluoro-3-[hydroxy[3-[2-(1-piperidinyl)ethoxy]phenyl]methyl]-(914910-55-7)

Safety Data

• Hazardous Substances Data: 914910-55-7(Hazardous Substances Data)

Upstream product

• 81068-27-1 3-(2-(piperidin-1-yl)ethoxy)benzaldehyde 
• 1194-02-1 4-fluorobenzonitrile 

Downstream Products

• 914910-56-8 C₂₁H₂₁FN₂O₂ 

Relevant articles and documents

Solid forms of a JNK inhibitor

The present invention provides solid forms of Compound (I), pharmaceutical compositions thereof, and methods for the treatment or prevention of diseases including, but not limited to a liver disease, cancer, a cardiovascular disease, a metabolic disease, a renal disease, an autoimmune condition, an inflammatory condition, macular degeneration, pain and related syndromes, disease-related wasting, an asbestos-related condition, pulmonary hypertension, ischemia/reperfusion injury, central nervous system (CNS) injury/damage or a disease treatable or preventable by the inhibition of JNK. In particular, the invention relates to certain novel crystal forms of the compound 1-(5-(1H-1,2,4-triazol-5-yl)(1H-indazol-3-yl))-3-(2-piperidylethoxy)benzene.